Unilever PLC (UL) Stock Price & How to Invest

Unilever PLC is one of the world's largest consumer-goods companies, and UL is its NYSE-listed ADR (the London line trades as ULVR, with a further listing in Amsterdam). After the late-2025 demerger of its ice cream arm, Unilever is organized around four business groups: Beauty & Wellbeing (Dove, Vaseline, and premium and wellness brands), Personal Care (deodorants, skin cleansing, and oral care such as Rexona and Lifebuoy), Home Care (laundry and cleaning brands like Persil and Cif), and Foods, also called Nutrition (Knorr, Hellmann's, and cooking products). A large share of turnover now comes from a concentrated set of roughly 30 Power Brands, which the company reports have been growing faster than the overall portfolio. Because it sells low-cost, repeat-purchase essentials, Unilever tends to hold up better than cyclical businesses in downturns, though it is exposed to input-cost inflation, currency swings, and slower volume growth in developed markets.

The mid-2026 picture is dominated by the reshaping under CEO Fernando Fernandez and his Growth Action Plan. In December 2025 Unilever completed the demerger of its ice cream business into The Magnum Ice Cream Company, distributing shares to existing holders (roughly one new share for every five Unilever shares) while keeping a minority stake to sell down over time. Management is shifting from a geography-led to a category-led model, concentrating investment on beauty, wellbeing, and personal care, and running a productivity program that includes thousands of office-role reductions to fund brand investment and lift margins. Fernandez has signaled a sharper focus on the US and India as priority markets. The strategy aims to reignite volume-led growth, but it is still early, and execution across a company this large carries real uncertainty.

The main risk is that a slow-growth staples business trades on the credibility of its turnaround: if the Growth Action Plan does not lift volumes and margins as hoped, the stock can languish. Input-cost inflation in commodities and packaging can squeeze margins, and heavy price increases risk losing volume to private label and cheaper rivals. As an ADR, UL results are reported in euros, so a stronger dollar reduces the dollar value of sales, earnings, and the dividend for US holders. Execution risk is real: management overhauls, thousands of role changes, and integrating the shift to a category-led model can distract the organization. The retained minority stake in The Magnum Ice Cream Company is an overhang the company plans to sell down, and some brands (such as Ben & Jerry's, now part of the demerged entity) have a history of activism-related controversy. Slower developed-market volumes and intense competition round out the picture.

4 analysts publish price targets on UL, averaging $73.59 against a $63.41 price as of August 2026, or +16.1%. The published targets run from $69.70 to $76.89, a narrow spread, and the ratings split 3 buy, 2 hold, 0 sell. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full UL forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Unilever PLC. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Power Brands and premiumization. Unilever has concentrated its portfolio on a smaller group of Power Brands (Dove, Knorr, Hellmann's, Vaseline, Rexona, and others) that make up the large majority of turnover and have been growing faster than the total business. The most optimistic published target, $76.89, assumes this works close to its best case.

The case against. The main risk is that a slow-growth staples business trades on the credibility of its turnaround: if the Growth Action Plan does not lift volumes and margins as hoped, the stock can languish. The most pessimistic target, $69.70, is roughly what UL is worth if this bites instead.

Read the full bull and bear case on UL, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Unilever PLC's investor relations page or your broker.

• Business mix: Four business groups after the ice cream demerger: Beauty & Wellbeing, Personal Care, Home Care, and Foods (Nutrition); verify live figures before acting
• Revenue scale: Tens of billions of euros in annual turnover (reported in euros; UL is a dollar-denominated ADR), spread across roughly 190 countries; verify live figures before acting
• Underlying sales growth: Mid-single-digit percentage in recent periods, led by Power Brands and beauty/personal care; verify the latest quarter before acting
• Dividend: Pays a quarterly dividend and is widely held as a defensive income stock; treat any specific yield as a live figure to confirm before acting
• Valuation style: Trades as a defensive consumer staple, typically on an earnings multiple in line with or modestly below large staples peers; verify live figures before acting
• ADR ratio: One UL ADR represents one Unilever PLC ordinary share; check the current ratio and any ADR fees before acting

Figures are qualitative and tied to the asOf date; verify live numbers before acting. Unilever is valued as a stable, cash-generative consumer staple rather than a fast grower, so its multiple hinges on whether the Growth Action Plan can lift volume growth and margins. Because it is an ADR of a euro-reporting company, currency moves affect the dollar figures US investors see, including the dividend, independent of how the underlying business performs.

Other names that sit close to UL: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get UL exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so UL sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where UL fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Unilever is a defensive, dividend-paying global staples company in the middle of a self-help turnaround: it has demerged ice cream, is tilting toward beauty and personal care, and is cutting costs behind its Power Brands. It rewards patient income and stability seekers, not investors chasing rapid growth.

Whether UL is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is UL a buy or a sell?, and where the stock could go from here in the UL stock forecast.

For income investors, whether UL pays a dividend and how the payout looks is covered in does UL pay a dividend? And to weigh UL against a peer, read the full side-by-side comparisons: UL vs PG and UL vs CL.